相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma
Charlee Nardin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms
Rong En Tay et al.
CANCER GENE THERAPY (2021)
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
Julie Westerlin Kjeldsen et al.
NATURE MEDICINE (2021)
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Pierre Dillard et al.
MOLECULAR THERAPY (2021)
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
Amelie Cachot et al.
SCIENCE ADVANCES (2021)
Recruiting T cells in cancer immunotherapy
Kathryn E. Yost et al.
SCIENCE (2021)
Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma-Five-Year Follow Up of a Phase I/IIa Trial
Elin Aamdal et al.
FRONTIERS IN IMMUNOLOGY (2021)
Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential
Espen Basmo Ellingsen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer
Jiajia Zhang et al.
CLINICAL CANCER RESEARCH (2020)
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer
Aleksandar Z. Obradovic et al.
CLINICAL CANCER RESEARCH (2020)
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma
Amber M. Johnson et al.
JOURNAL OF IMMUNOLOGY (2020)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
Paal F. Brunsvig et al.
FRONTIERS IN IMMUNOLOGY (2020)
Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung
Caroline Laheurte et al.
BRITISH JOURNAL OF CANCER (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis
Ricarda Hannen et al.
FEBS LETTERS (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance
Barbara Seliger et al.
ONCOIMMUNOLOGY (2017)
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
Wolfgang Lilleby et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response
Kristina Berg Lorvik et al.
CANCER RESEARCH (2016)
The Basis of Oncoimmunology
A. Karolina Palucka et al.
CELL (2016)
Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse
Yang Pu et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton et al.
LANCET ONCOLOGY (2014)
Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
R. Bertorelle et al.
BRITISH JOURNAL OF CANCER (2013)
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation
Rodney A. Rosalia et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells
Z. Liu et al.
ONCOGENE (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
Else-Marit Inderberg-Suso et al.
ONCOIMMUNOLOGY (2012)
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
Else M. Inderberg Suso et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination
Jon Amund Kyte et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
TNFR1 signaling and IFN-γ signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis
Nele Mueller-Hermelink et al.
CANCER CELL (2008)
Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy
Ravi A. Madan et al.
CLINICAL CANCER RESEARCH (2008)
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Kalliopi D. Tsakiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
Joseph P. Casazza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita
M Armanios et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia
H Yamaguchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Telomerase contributes to turnorigenesis by a telomere length-independent mechanism
SA Stewart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
